Business
ASX 200 drops 0.9% on Monday 11 January 2020
The S&P/ASX 200 Index (ASX: XJO) fell by almost 0.9% today to 6,697 points.
Here are the highlights from the ASX:
The Mesoblast share price went up 14% today after giving the market an update.
It announced today additional results from the landmark DREAM-HF randomised controlled phase 3 trial in 537 treated patients with chronic heart failure with reduced left ventricular ejection fraction (HFrEF) who received rexlemestrocel-L or control shame.
Mesoblast explained that a single dose of rexlemestrocel-L resulted in substantial and durable reductions in heart attacks, strokes and cardiac deaths.
The ASX 200 company said that existing therapies have only minimal or no benefit on these endpoints, these notable outcomes may signal a…
-
Noosa News17 hours agoProtest calls for shark net removal
-
General16 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News19 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General18 hours agoFederal politics live: Communications minister summons telco bosses to meeting